Market Insights Consumer OTC Pharmaceuticals

Wound Care - South America

South America

Revenue in the Wound Care market amounts to €111.30 in 2024. The market is expected to grow annually by -0.77% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975 in 2024).
In relation to total population figures, per person revenues of €0.27 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in South America is experiencing significant growth due to several factors.

Customer preferences: Customers in South America are increasingly seeking advanced wound care products that offer effective and efficient healing solutions. They are looking for products that are easy to use, promote faster healing, and provide long-lasting relief. Additionally, customers are becoming more conscious of the quality and safety of wound care products, preferring those that are made from natural ingredients and have minimal side effects.

Trends in the market: One of the key trends in the South American Wound Care market is the increasing adoption of advanced wound dressings. These dressings are designed to provide a moist wound healing environment, which accelerates the healing process and reduces the risk of infection. Additionally, there is a growing demand for wound care products that incorporate technologies such as antimicrobial agents and growth factors, which further enhance the healing process. Another trend in the market is the rising popularity of active wound care products. These products are specifically designed to stimulate the healing process by promoting cell growth and tissue regeneration. They are particularly beneficial for chronic wounds that are difficult to heal using traditional wound care methods. Active wound care products are gaining traction in South America due to their effectiveness and ability to provide long-term relief.

Local special circumstances: South America is home to a large population of diabetes patients, who are particularly susceptible to chronic wounds such as diabetic foot ulcers. This has created a significant demand for wound care products that cater to the specific needs of diabetic patients. Manufacturers are developing specialized wound dressings and treatments that are designed to address the unique challenges associated with diabetic wounds, such as reduced blood circulation and impaired healing.

Underlying macroeconomic factors: The growing middle-class population in South America, coupled with increasing healthcare expenditure, is driving the growth of the Wound Care market. As disposable incomes rise, consumers are willing to spend more on healthcare products, including wound care products. Additionally, the improving healthcare infrastructure and access to healthcare services in the region are also contributing to the market growth. In conclusion, the Wound Care market in South America is witnessing significant growth due to customer preferences for advanced and effective wound care products. The increasing adoption of advanced wound dressings and active wound care products is driving the market forward. Local special circumstances, such as the high prevalence of diabetes, are also contributing to the demand for specialized wound care products. Furthermore, underlying macroeconomic factors, such as the growing middle-class population and increasing healthcare expenditure, are fueling the market growth in South America.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.